Patient outcomes and clinical characteristics of ATTR-CM patients treated with tafamidis: A single center experience in Turkey - Study ATTREAL

First published 01/07/2025

Last updated 01/07/2025

EU PAS number:

EUPAS1000000561

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

B3461126_Non-Interventional Study Protocol_V1_21MAY2025_Redacted.pdf

English (12.34 MB - PDF)View document

Study results

Study report

Other information